Mark Philip has over 30 years’ experience in the Biopharma, Medical Device, Diagnostic and Health IT industries, operating in Europe, the USA and Asia. As CEO, president or board member of multiple start-ups, medium size and large businesses, Mark has orchestrated multiple turnarounds, built product pipelines, launched new products, sold companies and created significant shareholder value.
Mark has been a consultant to the industry since 2012, and a partner at Alacrita since 2016, advising on acquisitions, product development, commercial strategies and fund raising for a variety of small and large, private and public companies. Mark is also on the faculty at Boston University’s MBA Program and teaches advanced strategy in the pharmaceutical, medical device and diagnostics industries.
Mark has a bachelor’s degree in Biochemistry and a PhD in Stem Cell Research from Nottingham Trent University, Nottingham, UK, and was the Leukemia Research Fund Postdoctoral Research Fellow at Nottingham University. Mark also has an MBA from Lake Forest Graduate School of Management in Chicago, and completed an Advanced Leadership Program at Harvard University.
His management consulting experience includes advising CEOs on financings and introductions to investors, business development strategies, product development, technology evaluation and market appraisal, leveraging his scientific expertise and his business and leadership experience as a serial CEO in small and large companies.
Current role